文献速递贫血与红细胞疾病

全反式维甲酸通过靶向NFAT1信号使Th1向Th2细胞分化偏移以改善免疫介导的再生障碍性贫血

All-trans-retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune-mediated aplastic anaemia.
PubMed 文献 · Br J Haematol · 2020-07-29

该研究在免疫介导的再生障碍性贫血(AA)小鼠模型中测试全反式维甲酸(ATRA)作为替代治疗的可能性。结果显示ATRA抑制T细胞增殖、活化与效应功能,抑制Fas/Fasl通路,通过靶向NFAT1信号使Th1向Th2偏移并纠正Th1/Th2比值,同时抑制Th17分化并促进调节性T细胞发育。作者认为ATRA是改善AA治疗结局的有效药物。

要点

  • ATRA抑制T细胞增殖、活化与效应功能并抑制Fas/Fasl通路。
  • ATRA靶向NFAT1信号使Th1向Th2偏移并纠正Th1/Th2比值。
  • ATRA抑制Th17分化并促进调节性T细胞发育。

核心结论

  • 作者认为ATRA是改善再生障碍性贫血治疗结局的有效药物。

研究设计与样本

  • 研究使用免疫介导的再生障碍性贫血小鼠模型测试ATRA作为替代治疗的可能性。

主要发现

  • ATRA抑制T细胞增殖、活化与效应功能。
  • ATRA抑制Fas/Fasl通路。
  • ATRA使Th1向Th2细胞发育偏移,在相对较高水平重新平衡T细胞亚群并纠正Th1/Th2比值,其机制为靶向NFAT1信号。
  • ATRA抑制Th17细胞分化并促进调节性T细胞发育。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Severe acquired aplastic anaemia (AA) is a serious disease characterised by autoreactive T cells attacking haematopoietic stem cells, leading to marrow hypoplasia and pancytopenia. Immunosuppressive therapy combined with antithymocyte globulin and ciclosporin can rescue most patients with AA. However, the relapse after ciclosporin withdrawal and the severe side effects of long-term ciclosporin administration remain unresolved. As such, new strategies should be developed to supplement current therapeutics and treat AA. In this study, the possibility of all-trans-retinoic acid (ATRA) as an alternative AA treatment was tested by using an immune-mediated mouse model of AA. Results revealed that ATRA inhibited T-cell proliferation, activation and effector function. It also restrained the Fas/Fasl pathway, shifted Th1 towards Th2 cell development, rebalanced T-cell subsets at a relatively high level and corrected the Th1/Th2 ratio by targeting NFAT1 signalling. In addition, ATRA inhibited Th17 cell differentiation and promoted regulatory T-cell development. Therefore, ATRA was an effective agent to improve AA treatment outcomes.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Tang D, Liu S, Sun H, et al. All-trans-retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune-mediated aplastic anaemia. Br J Haematol. 2020. PMID: 32729137. doi:10.1111/bjh.16871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。